CAD 0.01
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -5.98 Million CAD | 60.46% |
2022 | -14.88 Million CAD | -215.7% |
2021 | 12.86 Million CAD | 156.37% |
2020 | -22.82 Million CAD | 61.75% |
2019 | -59.67 Million CAD | -305.63% |
2018 | -14.71 Million CAD | -891.61% |
2017 | -1.48 Million CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -2.74 Million CAD | -32.31% |
2024 Q1 | -2.1 Million CAD | 18.07% |
2023 Q2 | -1.88 Million CAD | -2910.1% |
2023 Q4 | -2.56 Million CAD | -133.02% |
2023 FY | -5.88 Million CAD | 60.46% |
2023 Q3 | -1.1 Million CAD | 41.69% |
2023 Q1 | -62.77 Thousand CAD | 99.49% |
2022 Q1 | -3.83 Million CAD | -111.58% |
2022 FY | -14.88 Million CAD | -215.7% |
2022 Q3 | -4.98 Million CAD | -181.0% |
2022 Q2 | 6.15 Million CAD | 260.73% |
2022 Q4 | -12.22 Million CAD | -145.13% |
2021 Q2 | -5.07 Million CAD | 23.24% |
2021 FY | 12.86 Million CAD | 156.37% |
2021 Q1 | -6.6 Million CAD | -98.45% |
2021 Q3 | -7.98 Million CAD | -57.37% |
2021 Q4 | 33.09 Million CAD | 514.56% |
2020 FY | -22.82 Million CAD | 61.75% |
2020 Q1 | -7.92 Million CAD | 72.72% |
2020 Q4 | -3.32 Million CAD | 41.87% |
2020 Q3 | -5.72 Million CAD | 1.85% |
2020 Q2 | -5.83 Million CAD | 26.38% |
2019 Q1 | -12.61 Million CAD | -502.29% |
2019 FY | -59.67 Million CAD | -305.63% |
2019 Q4 | -29.05 Million CAD | -170.71% |
2019 Q3 | -10.73 Million CAD | -11.9% |
2019 Q2 | -9.59 Million CAD | 23.98% |
2018 Q3 | -9.95 Million CAD | -370.75% |
2018 FY | -14.71 Million CAD | -891.61% |
2018 Q4 | -2.09 Million CAD | 78.96% |
2018 Q1 | -586.95 Thousand CAD | 48.68% |
2018 Q2 | -2.11 Million CAD | -260.29% |
2017 FY | -1.48 Million CAD | 0.0% |
2017 Q3 | -339.93 Thousand CAD | 0.0% |
2017 Q4 | -1.14 Million CAD | -236.44% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | -402.658% |
Ayurcann Holdings Corp. | -3.25 Million CAD | -84.147% |
Blueberries Medical Corp. | -1.22 Million CAD | -388.061% |
The BC Bud Corporation | -1.22 Million CAD | -389.294% |
BioNxt Solutions Inc. | -6.36 Million CAD | 5.982% |
CordovaCann Corp. | -2.51 Million CAD | -138.259% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -579.85% |
Captor Capital Corp. | 655.2 Thousand CAD | 1013.663% |
City View Green Holdings Inc. | -996.45 Thousand CAD | -500.773% |
1CM Inc. | 300.79 Thousand CAD | 2090.221% |
Global Hemp Group Inc. | -551.7 Thousand CAD | -985.068% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | -54.325% |
IM Cannabis Corp. | -12.17 Million CAD | 50.83% |
Lobe Sciences Ltd. | -3.35 Million CAD | -78.199% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1426.303% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -87.897% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 1203.953% |
Ovation Science Inc. | -764 Thousand CAD | -683.553% |
Pharmadrug Inc. | -1.33 Million CAD | -348.415% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | -424.215% |
RAMM Pharma Corp. | -7.08 Million CAD | 15.52% |
RIV Capital Inc. | 1.78 Million CAD | 436.27% |
Revive Therapeutics Ltd. | -3.28 Million CAD | -82.177% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 31.733% |
1933 Industries Inc. | -9.34 Million CAD | 35.97% |
Red Light Holland Corp. | -6.44 Million CAD | 7.136% |
Top Strike Resources Corp. | -784.8 Thousand CAD | -662.792% |
Xebra Brands Ltd. | -1.55 Million CAD | -285.092% |
Adastra Holdings Ltd. | -1.79 Million CAD | -233.735% |